These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1421379)

  • 1. Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency.
    Lemarchandel V; Joulin V; Valentin C; Rosa R; Galactéros F; Rosa J; Cohen-Solal M
    Blood; 1992 Nov; 80(10):2643-9. PubMed ID: 1421379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia.
    Xu G; van Bruggen R; Gualtieri CO; Moradin N; Fois A; Vallerand D; De Sa Tavares Russo M; Bassenden A; Lu W; Tam M; Lesage S; Girouard H; Avizonis DZ; Deblois G; Prchal JT; Stevenson M; Berghuis A; Muir T; Rabinowitz J; Vidal SM; Fodil N; Gros P
    Cell Rep; 2020 Sep; 32(12):108170. PubMed ID: 32966787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, characterization, and structure of a mutant 89 Arg----Cys bisphosphoglycerate mutase. Implication of the active site in the mutation.
    Rosa R; Blouquit Y; Calvin MC; Prome D; Prome JC; Rosa J
    J Biol Chem; 1989 May; 264(14):7837-43. PubMed ID: 2542247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
    Hoyer JD; Allen SL; Beutler E; Kubik K; West C; Fairbanks VF
    Am J Hematol; 2004 Apr; 75(4):205-8. PubMed ID: 15054810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human bisphosphoglycerate mutase. Expression in Escherichia coli and use of site-directed mutagenesis in the evaluation of the role of the carboxyl-terminal region in the enzymatic mechanism.
    Garel MC; Joulin V; Le Boulch P; Calvin MC; Préhu MO; Arous N; Longin R; Rosa R; Rosa J; Cohen-Solal M
    J Biol Chem; 1989 Nov; 264(32):18966-72. PubMed ID: 2553728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.
    van Dijk MJ; van Oirschot BA; Stam-Slob MC; Waanders E; van der Zwaag B; van Beers EJ; Jans JJM; van der Linden PW; Torregrosa Diaz JM; Gardie B; Girodon F; Schots R; Thielen N; van Wijk R
    Br J Haematol; 2023 Jan; 200(2):249-255. PubMed ID: 36177683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant bisphosphoglycerate mutase variant with acid phosphatase homology degrades 2,3-diphosphoglycerate.
    Garel MC; Arous N; Calvin MC; Craescu CT; Rosa J; Rosa R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3593-7. PubMed ID: 8170953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of the human 2,3-bisphosphoglycerate mutase cDNA and revised amino acid sequence.
    Cohen-Solal M; Joulin V; Romeo PH; Rosa R; Valentin C; Garel MC; Rosa J
    Biomed Biochim Acta; 1987; 46(2-3):S126-30. PubMed ID: 3036106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and sequencing of the human erythrocyte 2,3-bisphosphoglycerate mutase cDNA: revised amino acid sequence.
    Joulin V; Peduzzi J; Roméo PH; Rosa R; Valentin C; Dubart A; Lapeyre B; Blouquit Y; Garel MC; Goossens M
    EMBO J; 1986 Sep; 5(9):2275-83. PubMed ID: 3023066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and artificial mutants of the human 2,3-bisphosphoglycerate as a tool for the evaluation of structure-function relationships.
    Garel MC; Lemarchandel V; Prehu MO; Calvin MC; Arous N; Rosa R; Rosa J; Cohen-Solal M
    Biomed Biochim Acta; 1990; 49(2-3):S166-71. PubMed ID: 2167078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes.
    Rosa R; Prehu MO; Beuzard Y; Rosa J
    J Clin Invest; 1978 Nov; 62(5):907-15. PubMed ID: 152321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel placental expression of 2,3-bisphosphoglycerate mutase.
    Pritlove DC; Gu M; Boyd CA; Randeva HS; Vatish M
    Placenta; 2006 Aug; 27(8):924-7. PubMed ID: 16246416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal assignment of the human 2,3-bisphosphoglycerate mutase gene (BPGM) to region 7q34----7q22.
    Barichard F; Joulin V; Henry I; Garel MC; Valentin C; Rosa R; Cohen-Solal M; Junien C
    Hum Genet; 1987 Nov; 77(3):283-5. PubMed ID: 2824335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modeling of the human erythrocyte bisphosphoglycerate mutase.
    Craescu CT; Schaad O; Garel MC; Rosa R; Edelstein S
    Biochimie; 1992 Jun; 74(6):519-26. PubMed ID: 1387804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human erythrocyte bisphosphoglycerate mutase: inactivation by glycation in vivo and in vitro.
    Fujita T; Suzuki K; Tada T; Yoshihara Y; Hamaoka R; Uchida K; Matuo Y; Sasaki T; Hanafusa T; Taniguchi N
    J Biochem; 1998 Dec; 124(6):1237-44. PubMed ID: 9832630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.
    Tsujino S; Shanske S; Sakoda S; Fenichel G; DiMauro S
    Am J Hum Genet; 1993 Mar; 52(3):472-7. PubMed ID: 8447317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosis.
    Lazana I; Mohamedali A; Smith F; de Lavallade H; McLornan D; Raj K
    Br J Haematol; 2021 Jan; 192(1):220-223. PubMed ID: 33216349
    [No Abstract]   [Full Text] [Related]  

  • 18. An enzyme-linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes.
    Takubo T; Tsuda I; Tatsumi N; Kasuya K; Taniguchi Y; Fujita T; Uchida K; Matsuo Y; Hayashi T
    J Clin Lab Anal; 1998; 12(5):263-7. PubMed ID: 9773955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of laminin B1 polypeptide (LAMB1) and 2,3 bisphosphoglycerate mutase (BPGM) to the physical and genetic maps of BTA4.
    Wu X; Davis SK; Davis SL; Gallagher DS; Song Y; Brenneman RA; Yeh CC; Taylor JF
    Anim Genet; 2000 Aug; 31(4):282-3. PubMed ID: 11086543
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
    Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
    Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.